I was prepared to eye-roll, but this ACYF memo is the most comprehensive government document on psych meds I have seen yet.

Until all drugs are properly studied in the populations for which they are being used, the lack of specific evidence-based recommendations reinforces the need for close supervision and monitoring for patients receiving psychotropic medication for off-label uses.